Daisuke Tomizawa

Chief, Division of Leukemia and Lymphoma

National Center For Child Health and Development

Japan

Research Interests

Explore related searches

Professors in Japan Professors in Medical Science Medical Science professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Daisuke Tomizawa is the Chief of the Division of Leukemia and Lymphoma at the National Center for Child Health and Development in Japan. His research interests encompass hematopoietic cell transplantation, acute lymphoblastic leukemia, and pharmacogenetics in pediatric oncology. He is actively involved in addressing treatment protocols and outcomes for children with malignancies and inborn errors of immunity, as reflected in his recent publications.

Articles (13)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Daisuke Tomizawa

Research Interests

Explore related searches

Contact this professor

About

Articles (13)

Hematopoietic Cell Transplantation in a Patient With X‐Linked Chronic Granulomatous Disease With McLeod Phenotype

Hemostatic Dynamics Mainly Based on Hypofibrinolysis During Early‐Phase Interfant‐Type Chemotherapy in Three Infants with Acute Lymphoblastic Leukemia: Results from Japan Children's Cancer Group ThrombALL‐MLL‐17

Real-world Outcomes of Commercial Tisagenlecleucel for Children, Adolescents, and Young Adults With Acute Lymphoblastic Leukemia in Japan

High-dose cytarabine induction therapy and flow cytometric measurable residual disease monitoring for children with acute myeloid leukemia

Guideline for treating relapsed or refractory myeloid leukemia in children with Down syndrome

High DOCK1 expression identifies a distinct prognostic subgroup of pediatric acute myeloid leukemia: Results of the Japanese Pediatric Leukemia/Lymphoma Study Group AML‐05 trial

Pharmacogenetic implementation for CYP2C19 and pharmacokinetics of voriconazole in children with malignancy or inborn errors of immunity

Hematopoietic stem cell transplantation in two sisters with bone marrow failure associated with POLE gene variants

The PedAL/EuPAL Project: A Global Initiative to Address the Unmet Medical Needs of Pediatric Patients with Relapsed or Refractory Acute Myeloid Leukemia

Risk-Stratified Therapy for Pediatric Acute Myeloid Leukemia

Prevalence of pathogenic variants in cancer‐predisposing genes in second cancer after childhood solid cancers

Myelodysplastic syndrome in a patient with Barth syndrome (3‐methylglutaconic aciduria type II)

Evolution and optimization of therapies for acute lymphoblastic leukemia in infants

Collaborators (5)

Jun Matsubayashi

Hiroshi Moritake

Takao Deguchi

Hirotoshi Sakaguchi

Takahiro Kamiya

Make your next move.